Transcat (TRNS) PT Raised to $20.00 at Singular Research

Transcat (NASDAQ:TRNS) had its target price lifted by Singular Research from $15.30 to $20.00 in a research report released on Monday morning. The firm currently has a buy rating on the scientific and technical instruments company’s stock.

Separately, Zacks Investment Research upgraded Transcat from a hold rating to a buy rating and set a $18.00 price objective on the stock in a research report on Saturday, February 3rd.

Transcat (NASDAQ:TRNS) opened at $15.25 on Monday. The company has a current ratio of 2.24, a quick ratio of 1.53 and a debt-to-equity ratio of 0.61. The company has a market capitalization of $111.94, a PE ratio of 24.45, a PEG ratio of 2.96 and a beta of 0.40. Transcat has a 1 year low of $11.02 and a 1 year high of $16.49.

In other news, Director John T. Smith sold 2,000 shares of the stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the transaction, the director now directly owns 33,100 shares in the company, valued at approximately $519,670. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 8.80% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of TRNS. Northern Trust Corp boosted its holdings in Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after acquiring an additional 1,570 shares during the period. Vanguard Group Inc. boosted its holdings in Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after acquiring an additional 4,450 shares during the period. QCI Asset Management Inc. NY boosted its holdings in Transcat by 31.1% during the 3rd quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock valued at $437,000 after acquiring an additional 7,647 shares during the period. Quantum Capital Management purchased a new stake in Transcat during the 3rd quarter valued at about $696,000. Finally, Ameriprise Financial Inc. purchased a new stake in Transcat during the 3rd quarter valued at about $2,484,000. Institutional investors own 56.53% of the company’s stock.

WARNING: This report was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://sportsperspectives.com/2018/02/08/transcat-trns-pt-raised-to-20-00-at-singular-research.html.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply